NJR Medical Advisory Committee (MAC)
Chair’s report – Mr Tim Wilton
The MAC committee met three times during the year and the enforced ‘virtual’ nature of our meetings did not appear to have an adverse impact on the discussions, with extremely useful feedback to the NJR from the BOA and specialist societies on many issues. The committee also provides the NJR with the opportunity to share information with the specialist societies and ensure that they kept updated on developments, such as the new cloud-based data services portal ‘NJR Connect’, and the newly improved and automated NJR audit systems that are now actively in operation.
Representatives of the BOA and specialist societies have canvassed their opinion about a number of crucial issues including:
1) Patellar resurfacing and secondary resurfacing procedures;
2) Debridement Antibiotics and Implant Retention (DAIR) procedures for both hips and knees; and
3) Recent NICE guidance on arthroplasty, and the implications for the data collected and disseminated by the NJR.
These matters have been taken back to other NJR committees to formulate processes and policies, which will hopefully enable the issues of concern to be addressed more appropriately in the future. These ongoing issues are to be the subject of debate at the forthcoming specialist society meetings, which I, and Peter Howard, will attend to help inform those discussions.
Several important revisions to both the Annual Clinical Reports (to trusts, Health Boards and independent sector providers) and the Consultant Level Reports, have been introduced in the last year and feedback to the MAC was that these had been well received by the orthopaedic community. In particular, the inclusion in the new ACR appendices of information regarding the breakdown of revisions in the hospital unit by indication for revision, was found very helpful. Similarly, the breakdown of expected versus observed revisions by consultant for each individual unit’s primary activity ,was found to be a very useful adjunct to the information about the consultant’s whole practice, which has previously been, and remains, available.
Following the Cumberlege report there has been considerable activity from NHSEI in relation to the development of better more comprehensive registries and systems, to support patient safety in relation to implantable medical devices. The NJR is regarded as a ‘global exemplar’ for this sort of work and extensive discussions occurred in MAC regarding the advice that could be offered to these organisations, about setting up registries and the mechanisms for furnishing that advice. As the NJR Medical Director, I am actively involved in these developments and am keen to ensure that all necessary channels of advice from the BOA and specialist societies are as open and engaged as possible to facilitate this process.
Tim Wilton – 2021